Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results By: Simulations Plus, Inc. via Business Wire April 06, 2022 at 16:06 PM EDT Total revenue growth of 13%; Software revenue growth of 25%; Diluted Earnings Per Share (EPS) growth of 40% Board of Directors announces quarterly dividend of $0.06 per share Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter of fiscal 2022, ended February 28, 2022. “We generated solid revenue growth, improved margins and strong EPS growth during the second quarter, demonstrating the health of our business and the operating leverage in our model,” said Shawn O’Connor, chief executive officer of Simulations Plus. “Our software business continued its rapid expansion and our services business generated strong bookings and backlog growth with a large pipeline of opportunities.” “We delivered double-digit revenue increases across our three major software platforms as a result of our increased upsell efforts and the addition of 18 new customers,” added Mr. O’Connor. “MonolixSuite® revenue was especially strong, with 43% growth, and is now our second-highest selling software product. The 25% growth in our software business offset the 5% decline in our services business this quarter and software revenue is now contributing over 60% of our revenue. The results represent an encouraging first half of the fiscal year and demonstrate that we are on-pace to achieve our full-year goals.” Second Quarter Fiscal 2022 Financial Highlights (compared with the corresponding period last fiscal year): Total revenue increased 13% to $14.8 million; Software revenue increased 25% to $9.8 million, representing 66% of total revenue; Services revenue declined 5% to $5.0 million, representing 34% of total revenue; Gross profit increased 17% to $12.0 million; gross margin was 81%; Net income and diluted EPS of $4.4 million and $0.21 compared to $3.2 million and $0.15, respectively; Adjusted EBITDA of $7.2 million, representing 48% of total revenue. YTD Financial Highlights (compared with the corresponding period last fiscal year): Total revenue increased 14% to $27.2 million; Software revenue increased 23% to $17.1 million, representing 63% of total revenue; Services revenue increased 2% to $10.1 million, representing 37% of total revenue; Gross profit increased 17% to $21.6 million; gross margin was 79%; Net income and diluted EPS of $7.4 million and $0.36 compared to $5.7 million and $0.27, respectively; Adjusted EBITDA of $12.4 million, representing 46% of total revenue. Mr. O’Connor concluded, “Our performance was in line with our guidance during the first half of fiscal 2022. As we look to the second half of the year, we expect our software business to continue to deliver strong performance, combined with improved results in our services business. As a result, we remain confident in achieving our 10-15% revenue guidance for the full-year driven by a positive mix shift towards our higher-margin software offerings.” Quarterly Dividend The company’s Board of Directors declared a cash dividend of $0.06 per share of the company’s common stock, payable on May 2, 2022, to shareholders of record as of April 25, 2022. The declaration of any future dividends will be determined by the Board of Directors each quarter and will depend on earnings, financial condition, capital requirements, and other factors. Environmental, Social, and Governance (ESG) We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report. Webcast and Conference Call Details Shawn O’Connor, chief executive officer, and Will Frederick, chief financial officer, will host a conference call and webcast today at 5 p.m. Eastern Time to discuss details of the company’s performance for the quarter and certain forward-looking information. The call may be accessed by registering here or by dialing 1-201-389-0879. The webcast will be available on our website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call. Non-GAAP Definition Adjusted EBITDA is defined as earnings (loss) before interest, taxes, depreciation and amortization, stock-based compensation, and any acquisition or financial transaction-related expenses. Adjusted EBITDA represents a measure that we believe is customarily used by investors and analysts to evaluate the financial performance of companies in addition to the GAAP measures that we present. Our management also believes that Adjusted EBITDA is useful in evaluating our core operating results. However, Adjusted EBITDA is not a measure of financial performance under accounting principles generally accepted in the United States of America and should not be considered an alternative to net income or operating income as an indicator of our operating performance or to net cash provided by operating activities as a measure of our liquidity. The company’s Adjusted EBITDA measure may not provide information that is directly comparable to that provided by other companies in its industry, as other companies in its industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. About Simulations Plus Serving clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn. Forward-Looking Statements Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like “believe,” “expect,” and “anticipate” mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission. SIMULATIONS PLUS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) Three months ended February 28, Six months ended February 28, (in thousands, except per common share amounts) 2022 2021 2022 2021 Revenue Software $ 9,758 $ 7,827 $ 17,120 $ 13,975 Services 5,038 5,320 10,093 9,873 Total revenue 14,796 13,147 27,213 23,848 Cost of revenue Software 780 836 1,515 1,647 Services 2,050 2,075 4,071 3,697 Total cost of revenue 2,830 2,911 5,586 5,344 Gross profit 11,966 10,236 21,627 18,504 Operating expenses Research and development 902 1,292 1,784 2,101 Selling, general and administrative 5,584 5,458 10,572 9,866 Total operating expenses 6,486 6,750 12,356 11,967 Income from operations 5,480 3,486 9,271 6,537 Other income (expense), net 53 (63 ) 118 (118 ) Income before income taxes 5,533 3,423 9,389 6,419 Provision for income taxes (1,124 ) (212 ) (1,954 ) (729 ) Net Income $ 4,409 $ 3,211 $ 7,435 $ 5,690 Earnings per share Basic $ 0.22 $ 0.16 $ 0.37 $ 0.28 Diluted $ 0.21 $ 0.15 $ 0.36 $ 0.27 Weighted-average common shares outstanding Basic 20,177 20,006 20,164 19,968 Diluted 20,745 20,842 20,738 20,786 Other comprehensive income (loss), net of tax Foreign currency translation adjustments (38 ) (4 ) (275 ) (4 ) Comprehensive income $ 4,371 $ 3,207 $ 7,160 $ 5,686 SIMULATIONS PLUS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Audited) (In thousands, except share and per share amounts) February 28,2022 August 31,2021 ASSETS Current assets Cash and cash equivalents $ 60,373 $ 36,984 Accounts receivable, net of allowance for doubtful accounts of $12 and $78 15,039 9,851 Prepaid income taxes 449 1,012 Prepaid expenses and other current assets 3,573 4,846 Short-term investments 64,192 86,620 Total current assets 143,626 139,313 Long-term assets Capitalized computer software development costs, net of accumulated amortization of $15,062 and $14,438 8,529 7,646 Property and equipment, net 634 1,838 Operating lease right of use asset 1,653 1,276 Intellectual property, net of accumulated amortization of $7,231 and $6,516 9,754 10,469 Other intangible assets, net of accumulated amortization of $2,475 and $2,186 7,877 6,464 Goodwill 12,921 12,921 Other assets 50 51 Total assets $ 185,044 $ 179,978 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities Accounts payable $ 414 $ 387 Accrued payroll and other expenses 2,220 5,604 Contracts payable - current portion 4,793 4,550 Operating lease liability, current portion 336 382 Deferred revenue 1,241 651 Total current liabilities 9,004 11,574 Long-term liabilities Deferred income taxes, net 2,150 1,726 Operating lease liability 1,314 896 Total liabilities 12,468 14,196 Commitments and contingencies Shareholders' equity Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding - - Common stock, $0.001 par value and additional paid-in capital — 50,000,000 shares authorized, 20,181,784 and 20,141,521 shares issued and outstanding 135,472 133,418 Retained earnings 37,422 32,407 Accumulated other comprehensive loss (318 ) (43 ) Total shareholders' equity 172,576 165,782 Total liabilities and shareholders' equity $ 185,044 $ 179,978 SIMULATIONS PLUS, INC. Trended Financial Information* (Unaudited) 2021 2022 2021 2022 (in millions except earnings per share amounts) Q1 Q2 Q3 Q4 Q1 Q2 Fiscal Year Fiscal YTD Software revenue GastroPlus $ 3.3 $ 4.5 $ 5.4 $ 3.1 $ 4.0 $ 5.5 $ 16.3 $ 9.4 MonolixSuite 1.2 1.6 0.9 0.8 $ 1.6 $ 2.2 4.4 $ 3.8 ADMET Predictor 1.2 1.2 1.5 1.2 $ 1.5 $ 1.4 5.0 $ 2.9 Other 0.5 0.6 0.5 0.3 $ 0.3 $ 0.7 1.9 $ 1.0 Total software revenue $ 6.2 $ 7.8 $ 8.3 $ 5.4 $ 7.4 $ 9.8 $ 27.7 $ 17.1 Services revenue PKPD $ 2.2 $ 2.6 $ 1.9 $ 2.3 $ 2.3 $ 2.2 $ 9.1 $ 4.5 QSP/QST 1.1 1.7 1.2 1.1 $ 1.5 $ 1.5 5.1 $ 3.0 PBPK 0.6 0.9 0.7 0.7 $ 0.9 $ 0.9 3.0 $ 1.8 Other 0.5 - 0.6 0.3 $ 0.3 $ 0.4 1.4 $ 0.8 Total services revenue $ 4.5 $ 5.3 $ 4.4 $ 4.4 $ 5.0 $ 5.0 # $ 18.8 $ 10.1 Total consolidated revenue $ 10.7 $ 13.1 $ 12.8 $ 9.8 $ 12.4 $ 14.8 # $ 46.5 $ 27.2 Gross Margin Software 86.9 % 89.0 % 90.0 % 85.0 % 90.0 % 92.0 % 88.0 % 91.2 % Services 63.9 % 61.0 % 63.0 % 55.0 % 60.0 % 59.3 % 61.0 % 59.7 % Total 77.3 % 77.9 % 80.7 % 71.7 % 77.8 % 80.9 % 77.2 % 79.5 % Income from operations $ 3.1 $ 3.5 $ 4.5 $ 0.2 $ 3.8 $ 5.5 $ 11.3 $ 9.3 Operating Margin 28.5 % 26.6 % 35.6 % 1.8 % 30.6 % 37.0 % 24.2 % 34.1 % Net Income $ 2.5 $ 3.2 $ 3.8 $ 0.3 $ 3.0 $ 4.4 $ 9.8 $ 7.4 Diluted Earnings Per Share $ 0.12 $ 0.15 $ 0.18 $ 0.01 $ 0.15 $ 0.21 $ 0.47 $ 0.36 Adjusted EBITDA $ 4.3 $ 5.0 $ 5.9 $ 1.7 $ 5.3 $ 7.2 $ 16.9 $ 12.4 Cash Flow from Operations $ 5.3 $ 1.3 $ 4.3 $ 8.3 $ 3.6 $ 2.6 $ 19.2 $ 6.2 Revenue Breakdown by Region Americas $ 7.1 $ 8.7 $ 9.7 $ 7.1 $ 8.5 $ 9.7 32.5 $ 18.2 EMEA 2.5 3.1 1.5 0.9 3.0 3.7 7.9 6.7 Asia Pacific 1.1 1.4 1.7 1.8 0.9 1.4 6.0 2.3 Total consolidated revenue $ 10.7 $ 13.1 $ 12.8 $ 9.8 $ 12.4 $ 14.8 $ 46.6 $ 27.2 Software Performance Metrics Average Revenue per Customer (in thousands) Commercial $ 74.0 $ 84.0 $ 98.0 $ 65.0 $ 71.0 $ 101.0 Services Performance Metrics Backlog $ 12.0 $ 11.2 $ 12.4 $ 13.0 $ 15.4 $ 17.0 *Numbers may not add due to rounding SIMULATIONS PLUS, INC. Reconciliation of Adjusted EBITDA to Net Income (Unaudited) 2021 2022 2021 2022 (in millions) Q1 Q2 Q3 Q4 Q1 Q2 Fiscal Year Fiscal YTD Net Income $ 2.5 $ 3.2 $ 3.8 $ 0.3 $ 3.0 $ 4.4 $ 9.8 $ 7.4 Excluding: Interest income and expense, net (0.1) (0.0) (0.0) (0.0) (0.1) (0.1) (0.2) (0.1) Provision for income taxes 0.5 0.2 0.7 (0.1) 0.8 1.1 1.3 2.0 Depreciation and amortization 0.9 0.9 0.9 1.0 0.8 1.0 3.6 1.8 Stock-based compensation 0.5 0.7 0.6 0.6 0.6 0.7 2.4 1.3 Adjusted EBITDA $ 4.3 $ 5.0 $ 5.9 $ 1.7 $ 5.3 $ 7.2 $ 16.9 $ 12.4 View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005495/en/Contacts Investor Relations Contacts: Renee Bouche Simulations Plus Investor Relations 661-723-7723 renee.bouche@simulations-plus.com Brian Siegel Hayden IR 346-396-8696 brian@haydenir.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results By: Simulations Plus, Inc. via Business Wire April 06, 2022 at 16:06 PM EDT Total revenue growth of 13%; Software revenue growth of 25%; Diluted Earnings Per Share (EPS) growth of 40% Board of Directors announces quarterly dividend of $0.06 per share Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter of fiscal 2022, ended February 28, 2022. “We generated solid revenue growth, improved margins and strong EPS growth during the second quarter, demonstrating the health of our business and the operating leverage in our model,” said Shawn O’Connor, chief executive officer of Simulations Plus. “Our software business continued its rapid expansion and our services business generated strong bookings and backlog growth with a large pipeline of opportunities.” “We delivered double-digit revenue increases across our three major software platforms as a result of our increased upsell efforts and the addition of 18 new customers,” added Mr. O’Connor. “MonolixSuite® revenue was especially strong, with 43% growth, and is now our second-highest selling software product. The 25% growth in our software business offset the 5% decline in our services business this quarter and software revenue is now contributing over 60% of our revenue. The results represent an encouraging first half of the fiscal year and demonstrate that we are on-pace to achieve our full-year goals.” Second Quarter Fiscal 2022 Financial Highlights (compared with the corresponding period last fiscal year): Total revenue increased 13% to $14.8 million; Software revenue increased 25% to $9.8 million, representing 66% of total revenue; Services revenue declined 5% to $5.0 million, representing 34% of total revenue; Gross profit increased 17% to $12.0 million; gross margin was 81%; Net income and diluted EPS of $4.4 million and $0.21 compared to $3.2 million and $0.15, respectively; Adjusted EBITDA of $7.2 million, representing 48% of total revenue. YTD Financial Highlights (compared with the corresponding period last fiscal year): Total revenue increased 14% to $27.2 million; Software revenue increased 23% to $17.1 million, representing 63% of total revenue; Services revenue increased 2% to $10.1 million, representing 37% of total revenue; Gross profit increased 17% to $21.6 million; gross margin was 79%; Net income and diluted EPS of $7.4 million and $0.36 compared to $5.7 million and $0.27, respectively; Adjusted EBITDA of $12.4 million, representing 46% of total revenue. Mr. O’Connor concluded, “Our performance was in line with our guidance during the first half of fiscal 2022. As we look to the second half of the year, we expect our software business to continue to deliver strong performance, combined with improved results in our services business. As a result, we remain confident in achieving our 10-15% revenue guidance for the full-year driven by a positive mix shift towards our higher-margin software offerings.” Quarterly Dividend The company’s Board of Directors declared a cash dividend of $0.06 per share of the company’s common stock, payable on May 2, 2022, to shareholders of record as of April 25, 2022. The declaration of any future dividends will be determined by the Board of Directors each quarter and will depend on earnings, financial condition, capital requirements, and other factors. Environmental, Social, and Governance (ESG) We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report. Webcast and Conference Call Details Shawn O’Connor, chief executive officer, and Will Frederick, chief financial officer, will host a conference call and webcast today at 5 p.m. Eastern Time to discuss details of the company’s performance for the quarter and certain forward-looking information. The call may be accessed by registering here or by dialing 1-201-389-0879. The webcast will be available on our website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call. Non-GAAP Definition Adjusted EBITDA is defined as earnings (loss) before interest, taxes, depreciation and amortization, stock-based compensation, and any acquisition or financial transaction-related expenses. Adjusted EBITDA represents a measure that we believe is customarily used by investors and analysts to evaluate the financial performance of companies in addition to the GAAP measures that we present. Our management also believes that Adjusted EBITDA is useful in evaluating our core operating results. However, Adjusted EBITDA is not a measure of financial performance under accounting principles generally accepted in the United States of America and should not be considered an alternative to net income or operating income as an indicator of our operating performance or to net cash provided by operating activities as a measure of our liquidity. The company’s Adjusted EBITDA measure may not provide information that is directly comparable to that provided by other companies in its industry, as other companies in its industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. About Simulations Plus Serving clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn. Forward-Looking Statements Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like “believe,” “expect,” and “anticipate” mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission. SIMULATIONS PLUS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) Three months ended February 28, Six months ended February 28, (in thousands, except per common share amounts) 2022 2021 2022 2021 Revenue Software $ 9,758 $ 7,827 $ 17,120 $ 13,975 Services 5,038 5,320 10,093 9,873 Total revenue 14,796 13,147 27,213 23,848 Cost of revenue Software 780 836 1,515 1,647 Services 2,050 2,075 4,071 3,697 Total cost of revenue 2,830 2,911 5,586 5,344 Gross profit 11,966 10,236 21,627 18,504 Operating expenses Research and development 902 1,292 1,784 2,101 Selling, general and administrative 5,584 5,458 10,572 9,866 Total operating expenses 6,486 6,750 12,356 11,967 Income from operations 5,480 3,486 9,271 6,537 Other income (expense), net 53 (63 ) 118 (118 ) Income before income taxes 5,533 3,423 9,389 6,419 Provision for income taxes (1,124 ) (212 ) (1,954 ) (729 ) Net Income $ 4,409 $ 3,211 $ 7,435 $ 5,690 Earnings per share Basic $ 0.22 $ 0.16 $ 0.37 $ 0.28 Diluted $ 0.21 $ 0.15 $ 0.36 $ 0.27 Weighted-average common shares outstanding Basic 20,177 20,006 20,164 19,968 Diluted 20,745 20,842 20,738 20,786 Other comprehensive income (loss), net of tax Foreign currency translation adjustments (38 ) (4 ) (275 ) (4 ) Comprehensive income $ 4,371 $ 3,207 $ 7,160 $ 5,686 SIMULATIONS PLUS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Audited) (In thousands, except share and per share amounts) February 28,2022 August 31,2021 ASSETS Current assets Cash and cash equivalents $ 60,373 $ 36,984 Accounts receivable, net of allowance for doubtful accounts of $12 and $78 15,039 9,851 Prepaid income taxes 449 1,012 Prepaid expenses and other current assets 3,573 4,846 Short-term investments 64,192 86,620 Total current assets 143,626 139,313 Long-term assets Capitalized computer software development costs, net of accumulated amortization of $15,062 and $14,438 8,529 7,646 Property and equipment, net 634 1,838 Operating lease right of use asset 1,653 1,276 Intellectual property, net of accumulated amortization of $7,231 and $6,516 9,754 10,469 Other intangible assets, net of accumulated amortization of $2,475 and $2,186 7,877 6,464 Goodwill 12,921 12,921 Other assets 50 51 Total assets $ 185,044 $ 179,978 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities Accounts payable $ 414 $ 387 Accrued payroll and other expenses 2,220 5,604 Contracts payable - current portion 4,793 4,550 Operating lease liability, current portion 336 382 Deferred revenue 1,241 651 Total current liabilities 9,004 11,574 Long-term liabilities Deferred income taxes, net 2,150 1,726 Operating lease liability 1,314 896 Total liabilities 12,468 14,196 Commitments and contingencies Shareholders' equity Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding - - Common stock, $0.001 par value and additional paid-in capital — 50,000,000 shares authorized, 20,181,784 and 20,141,521 shares issued and outstanding 135,472 133,418 Retained earnings 37,422 32,407 Accumulated other comprehensive loss (318 ) (43 ) Total shareholders' equity 172,576 165,782 Total liabilities and shareholders' equity $ 185,044 $ 179,978 SIMULATIONS PLUS, INC. Trended Financial Information* (Unaudited) 2021 2022 2021 2022 (in millions except earnings per share amounts) Q1 Q2 Q3 Q4 Q1 Q2 Fiscal Year Fiscal YTD Software revenue GastroPlus $ 3.3 $ 4.5 $ 5.4 $ 3.1 $ 4.0 $ 5.5 $ 16.3 $ 9.4 MonolixSuite 1.2 1.6 0.9 0.8 $ 1.6 $ 2.2 4.4 $ 3.8 ADMET Predictor 1.2 1.2 1.5 1.2 $ 1.5 $ 1.4 5.0 $ 2.9 Other 0.5 0.6 0.5 0.3 $ 0.3 $ 0.7 1.9 $ 1.0 Total software revenue $ 6.2 $ 7.8 $ 8.3 $ 5.4 $ 7.4 $ 9.8 $ 27.7 $ 17.1 Services revenue PKPD $ 2.2 $ 2.6 $ 1.9 $ 2.3 $ 2.3 $ 2.2 $ 9.1 $ 4.5 QSP/QST 1.1 1.7 1.2 1.1 $ 1.5 $ 1.5 5.1 $ 3.0 PBPK 0.6 0.9 0.7 0.7 $ 0.9 $ 0.9 3.0 $ 1.8 Other 0.5 - 0.6 0.3 $ 0.3 $ 0.4 1.4 $ 0.8 Total services revenue $ 4.5 $ 5.3 $ 4.4 $ 4.4 $ 5.0 $ 5.0 # $ 18.8 $ 10.1 Total consolidated revenue $ 10.7 $ 13.1 $ 12.8 $ 9.8 $ 12.4 $ 14.8 # $ 46.5 $ 27.2 Gross Margin Software 86.9 % 89.0 % 90.0 % 85.0 % 90.0 % 92.0 % 88.0 % 91.2 % Services 63.9 % 61.0 % 63.0 % 55.0 % 60.0 % 59.3 % 61.0 % 59.7 % Total 77.3 % 77.9 % 80.7 % 71.7 % 77.8 % 80.9 % 77.2 % 79.5 % Income from operations $ 3.1 $ 3.5 $ 4.5 $ 0.2 $ 3.8 $ 5.5 $ 11.3 $ 9.3 Operating Margin 28.5 % 26.6 % 35.6 % 1.8 % 30.6 % 37.0 % 24.2 % 34.1 % Net Income $ 2.5 $ 3.2 $ 3.8 $ 0.3 $ 3.0 $ 4.4 $ 9.8 $ 7.4 Diluted Earnings Per Share $ 0.12 $ 0.15 $ 0.18 $ 0.01 $ 0.15 $ 0.21 $ 0.47 $ 0.36 Adjusted EBITDA $ 4.3 $ 5.0 $ 5.9 $ 1.7 $ 5.3 $ 7.2 $ 16.9 $ 12.4 Cash Flow from Operations $ 5.3 $ 1.3 $ 4.3 $ 8.3 $ 3.6 $ 2.6 $ 19.2 $ 6.2 Revenue Breakdown by Region Americas $ 7.1 $ 8.7 $ 9.7 $ 7.1 $ 8.5 $ 9.7 32.5 $ 18.2 EMEA 2.5 3.1 1.5 0.9 3.0 3.7 7.9 6.7 Asia Pacific 1.1 1.4 1.7 1.8 0.9 1.4 6.0 2.3 Total consolidated revenue $ 10.7 $ 13.1 $ 12.8 $ 9.8 $ 12.4 $ 14.8 $ 46.6 $ 27.2 Software Performance Metrics Average Revenue per Customer (in thousands) Commercial $ 74.0 $ 84.0 $ 98.0 $ 65.0 $ 71.0 $ 101.0 Services Performance Metrics Backlog $ 12.0 $ 11.2 $ 12.4 $ 13.0 $ 15.4 $ 17.0 *Numbers may not add due to rounding SIMULATIONS PLUS, INC. Reconciliation of Adjusted EBITDA to Net Income (Unaudited) 2021 2022 2021 2022 (in millions) Q1 Q2 Q3 Q4 Q1 Q2 Fiscal Year Fiscal YTD Net Income $ 2.5 $ 3.2 $ 3.8 $ 0.3 $ 3.0 $ 4.4 $ 9.8 $ 7.4 Excluding: Interest income and expense, net (0.1) (0.0) (0.0) (0.0) (0.1) (0.1) (0.2) (0.1) Provision for income taxes 0.5 0.2 0.7 (0.1) 0.8 1.1 1.3 2.0 Depreciation and amortization 0.9 0.9 0.9 1.0 0.8 1.0 3.6 1.8 Stock-based compensation 0.5 0.7 0.6 0.6 0.6 0.7 2.4 1.3 Adjusted EBITDA $ 4.3 $ 5.0 $ 5.9 $ 1.7 $ 5.3 $ 7.2 $ 16.9 $ 12.4 View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005495/en/Contacts Investor Relations Contacts: Renee Bouche Simulations Plus Investor Relations 661-723-7723 renee.bouche@simulations-plus.com Brian Siegel Hayden IR 346-396-8696 brian@haydenir.com
Total revenue growth of 13%; Software revenue growth of 25%; Diluted Earnings Per Share (EPS) growth of 40% Board of Directors announces quarterly dividend of $0.06 per share
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter of fiscal 2022, ended February 28, 2022. “We generated solid revenue growth, improved margins and strong EPS growth during the second quarter, demonstrating the health of our business and the operating leverage in our model,” said Shawn O’Connor, chief executive officer of Simulations Plus. “Our software business continued its rapid expansion and our services business generated strong bookings and backlog growth with a large pipeline of opportunities.” “We delivered double-digit revenue increases across our three major software platforms as a result of our increased upsell efforts and the addition of 18 new customers,” added Mr. O’Connor. “MonolixSuite® revenue was especially strong, with 43% growth, and is now our second-highest selling software product. The 25% growth in our software business offset the 5% decline in our services business this quarter and software revenue is now contributing over 60% of our revenue. The results represent an encouraging first half of the fiscal year and demonstrate that we are on-pace to achieve our full-year goals.” Second Quarter Fiscal 2022 Financial Highlights (compared with the corresponding period last fiscal year): Total revenue increased 13% to $14.8 million; Software revenue increased 25% to $9.8 million, representing 66% of total revenue; Services revenue declined 5% to $5.0 million, representing 34% of total revenue; Gross profit increased 17% to $12.0 million; gross margin was 81%; Net income and diluted EPS of $4.4 million and $0.21 compared to $3.2 million and $0.15, respectively; Adjusted EBITDA of $7.2 million, representing 48% of total revenue. YTD Financial Highlights (compared with the corresponding period last fiscal year): Total revenue increased 14% to $27.2 million; Software revenue increased 23% to $17.1 million, representing 63% of total revenue; Services revenue increased 2% to $10.1 million, representing 37% of total revenue; Gross profit increased 17% to $21.6 million; gross margin was 79%; Net income and diluted EPS of $7.4 million and $0.36 compared to $5.7 million and $0.27, respectively; Adjusted EBITDA of $12.4 million, representing 46% of total revenue. Mr. O’Connor concluded, “Our performance was in line with our guidance during the first half of fiscal 2022. As we look to the second half of the year, we expect our software business to continue to deliver strong performance, combined with improved results in our services business. As a result, we remain confident in achieving our 10-15% revenue guidance for the full-year driven by a positive mix shift towards our higher-margin software offerings.” Quarterly Dividend The company’s Board of Directors declared a cash dividend of $0.06 per share of the company’s common stock, payable on May 2, 2022, to shareholders of record as of April 25, 2022. The declaration of any future dividends will be determined by the Board of Directors each quarter and will depend on earnings, financial condition, capital requirements, and other factors. Environmental, Social, and Governance (ESG) We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report. Webcast and Conference Call Details Shawn O’Connor, chief executive officer, and Will Frederick, chief financial officer, will host a conference call and webcast today at 5 p.m. Eastern Time to discuss details of the company’s performance for the quarter and certain forward-looking information. The call may be accessed by registering here or by dialing 1-201-389-0879. The webcast will be available on our website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call. Non-GAAP Definition Adjusted EBITDA is defined as earnings (loss) before interest, taxes, depreciation and amortization, stock-based compensation, and any acquisition or financial transaction-related expenses. Adjusted EBITDA represents a measure that we believe is customarily used by investors and analysts to evaluate the financial performance of companies in addition to the GAAP measures that we present. Our management also believes that Adjusted EBITDA is useful in evaluating our core operating results. However, Adjusted EBITDA is not a measure of financial performance under accounting principles generally accepted in the United States of America and should not be considered an alternative to net income or operating income as an indicator of our operating performance or to net cash provided by operating activities as a measure of our liquidity. The company’s Adjusted EBITDA measure may not provide information that is directly comparable to that provided by other companies in its industry, as other companies in its industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. About Simulations Plus Serving clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn. Forward-Looking Statements Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like “believe,” “expect,” and “anticipate” mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission. SIMULATIONS PLUS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) Three months ended February 28, Six months ended February 28, (in thousands, except per common share amounts) 2022 2021 2022 2021 Revenue Software $ 9,758 $ 7,827 $ 17,120 $ 13,975 Services 5,038 5,320 10,093 9,873 Total revenue 14,796 13,147 27,213 23,848 Cost of revenue Software 780 836 1,515 1,647 Services 2,050 2,075 4,071 3,697 Total cost of revenue 2,830 2,911 5,586 5,344 Gross profit 11,966 10,236 21,627 18,504 Operating expenses Research and development 902 1,292 1,784 2,101 Selling, general and administrative 5,584 5,458 10,572 9,866 Total operating expenses 6,486 6,750 12,356 11,967 Income from operations 5,480 3,486 9,271 6,537 Other income (expense), net 53 (63 ) 118 (118 ) Income before income taxes 5,533 3,423 9,389 6,419 Provision for income taxes (1,124 ) (212 ) (1,954 ) (729 ) Net Income $ 4,409 $ 3,211 $ 7,435 $ 5,690 Earnings per share Basic $ 0.22 $ 0.16 $ 0.37 $ 0.28 Diluted $ 0.21 $ 0.15 $ 0.36 $ 0.27 Weighted-average common shares outstanding Basic 20,177 20,006 20,164 19,968 Diluted 20,745 20,842 20,738 20,786 Other comprehensive income (loss), net of tax Foreign currency translation adjustments (38 ) (4 ) (275 ) (4 ) Comprehensive income $ 4,371 $ 3,207 $ 7,160 $ 5,686 SIMULATIONS PLUS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Audited) (In thousands, except share and per share amounts) February 28,2022 August 31,2021 ASSETS Current assets Cash and cash equivalents $ 60,373 $ 36,984 Accounts receivable, net of allowance for doubtful accounts of $12 and $78 15,039 9,851 Prepaid income taxes 449 1,012 Prepaid expenses and other current assets 3,573 4,846 Short-term investments 64,192 86,620 Total current assets 143,626 139,313 Long-term assets Capitalized computer software development costs, net of accumulated amortization of $15,062 and $14,438 8,529 7,646 Property and equipment, net 634 1,838 Operating lease right of use asset 1,653 1,276 Intellectual property, net of accumulated amortization of $7,231 and $6,516 9,754 10,469 Other intangible assets, net of accumulated amortization of $2,475 and $2,186 7,877 6,464 Goodwill 12,921 12,921 Other assets 50 51 Total assets $ 185,044 $ 179,978 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities Accounts payable $ 414 $ 387 Accrued payroll and other expenses 2,220 5,604 Contracts payable - current portion 4,793 4,550 Operating lease liability, current portion 336 382 Deferred revenue 1,241 651 Total current liabilities 9,004 11,574 Long-term liabilities Deferred income taxes, net 2,150 1,726 Operating lease liability 1,314 896 Total liabilities 12,468 14,196 Commitments and contingencies Shareholders' equity Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding - - Common stock, $0.001 par value and additional paid-in capital — 50,000,000 shares authorized, 20,181,784 and 20,141,521 shares issued and outstanding 135,472 133,418 Retained earnings 37,422 32,407 Accumulated other comprehensive loss (318 ) (43 ) Total shareholders' equity 172,576 165,782 Total liabilities and shareholders' equity $ 185,044 $ 179,978 SIMULATIONS PLUS, INC. Trended Financial Information* (Unaudited) 2021 2022 2021 2022 (in millions except earnings per share amounts) Q1 Q2 Q3 Q4 Q1 Q2 Fiscal Year Fiscal YTD Software revenue GastroPlus $ 3.3 $ 4.5 $ 5.4 $ 3.1 $ 4.0 $ 5.5 $ 16.3 $ 9.4 MonolixSuite 1.2 1.6 0.9 0.8 $ 1.6 $ 2.2 4.4 $ 3.8 ADMET Predictor 1.2 1.2 1.5 1.2 $ 1.5 $ 1.4 5.0 $ 2.9 Other 0.5 0.6 0.5 0.3 $ 0.3 $ 0.7 1.9 $ 1.0 Total software revenue $ 6.2 $ 7.8 $ 8.3 $ 5.4 $ 7.4 $ 9.8 $ 27.7 $ 17.1 Services revenue PKPD $ 2.2 $ 2.6 $ 1.9 $ 2.3 $ 2.3 $ 2.2 $ 9.1 $ 4.5 QSP/QST 1.1 1.7 1.2 1.1 $ 1.5 $ 1.5 5.1 $ 3.0 PBPK 0.6 0.9 0.7 0.7 $ 0.9 $ 0.9 3.0 $ 1.8 Other 0.5 - 0.6 0.3 $ 0.3 $ 0.4 1.4 $ 0.8 Total services revenue $ 4.5 $ 5.3 $ 4.4 $ 4.4 $ 5.0 $ 5.0 # $ 18.8 $ 10.1 Total consolidated revenue $ 10.7 $ 13.1 $ 12.8 $ 9.8 $ 12.4 $ 14.8 # $ 46.5 $ 27.2 Gross Margin Software 86.9 % 89.0 % 90.0 % 85.0 % 90.0 % 92.0 % 88.0 % 91.2 % Services 63.9 % 61.0 % 63.0 % 55.0 % 60.0 % 59.3 % 61.0 % 59.7 % Total 77.3 % 77.9 % 80.7 % 71.7 % 77.8 % 80.9 % 77.2 % 79.5 % Income from operations $ 3.1 $ 3.5 $ 4.5 $ 0.2 $ 3.8 $ 5.5 $ 11.3 $ 9.3 Operating Margin 28.5 % 26.6 % 35.6 % 1.8 % 30.6 % 37.0 % 24.2 % 34.1 % Net Income $ 2.5 $ 3.2 $ 3.8 $ 0.3 $ 3.0 $ 4.4 $ 9.8 $ 7.4 Diluted Earnings Per Share $ 0.12 $ 0.15 $ 0.18 $ 0.01 $ 0.15 $ 0.21 $ 0.47 $ 0.36 Adjusted EBITDA $ 4.3 $ 5.0 $ 5.9 $ 1.7 $ 5.3 $ 7.2 $ 16.9 $ 12.4 Cash Flow from Operations $ 5.3 $ 1.3 $ 4.3 $ 8.3 $ 3.6 $ 2.6 $ 19.2 $ 6.2 Revenue Breakdown by Region Americas $ 7.1 $ 8.7 $ 9.7 $ 7.1 $ 8.5 $ 9.7 32.5 $ 18.2 EMEA 2.5 3.1 1.5 0.9 3.0 3.7 7.9 6.7 Asia Pacific 1.1 1.4 1.7 1.8 0.9 1.4 6.0 2.3 Total consolidated revenue $ 10.7 $ 13.1 $ 12.8 $ 9.8 $ 12.4 $ 14.8 $ 46.6 $ 27.2 Software Performance Metrics Average Revenue per Customer (in thousands) Commercial $ 74.0 $ 84.0 $ 98.0 $ 65.0 $ 71.0 $ 101.0 Services Performance Metrics Backlog $ 12.0 $ 11.2 $ 12.4 $ 13.0 $ 15.4 $ 17.0 *Numbers may not add due to rounding SIMULATIONS PLUS, INC. Reconciliation of Adjusted EBITDA to Net Income (Unaudited) 2021 2022 2021 2022 (in millions) Q1 Q2 Q3 Q4 Q1 Q2 Fiscal Year Fiscal YTD Net Income $ 2.5 $ 3.2 $ 3.8 $ 0.3 $ 3.0 $ 4.4 $ 9.8 $ 7.4 Excluding: Interest income and expense, net (0.1) (0.0) (0.0) (0.0) (0.1) (0.1) (0.2) (0.1) Provision for income taxes 0.5 0.2 0.7 (0.1) 0.8 1.1 1.3 2.0 Depreciation and amortization 0.9 0.9 0.9 1.0 0.8 1.0 3.6 1.8 Stock-based compensation 0.5 0.7 0.6 0.6 0.6 0.7 2.4 1.3 Adjusted EBITDA $ 4.3 $ 5.0 $ 5.9 $ 1.7 $ 5.3 $ 7.2 $ 16.9 $ 12.4 View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005495/en/
Investor Relations Contacts: Renee Bouche Simulations Plus Investor Relations 661-723-7723 renee.bouche@simulations-plus.com Brian Siegel Hayden IR 346-396-8696 brian@haydenir.com
